Cti Biopharma

Developer of targeted small molecule therapeutics for blood cancer

placeSeattle, Washington, United States calendar_todayFounded 1991 groups25 employees language ctibiopharma.com

Registered entities

Innovation

11 patent families (8 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 258 times.

YearFilings
20131
20143
20155
20163
20174
20183
20192
20204
20216
20224
20231
20242

Investor mix

6 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital467%
Private equity117%
Bank & private debt117%
Coming soon